心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2016 IAS共识声明：严重家族性高胆固醇血症的定义和临床管理意义

2016-05-27 国际动脉粥样硬化学会 Lancet Diabetes Endocrinol. 2016 May 27

高胆固醇血症

2016年5月，国际动脉粥样硬化学会(IAS)严重家族性高胆固醇血症小组发布了关于严重家族性高胆固醇血症的定义和临床管理意义的共识声明，文章评估了分子生物学特征的重要性以及其他心血管危险因素，晚期亚临床冠状动脉粥样硬化的定义，严重家族性高胆固醇血症患者可从早期积极降脂治疗中获益。

中文标题：

2016 IAS共识声明：严重家族性高胆固醇血症的定义和临床管理意义

英文标题：

Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel.

发布机构：

国际动脉粥样硬化学会

发布日期：

2016-05-27

简要介绍：

2016年5月，国际动脉粥样硬化学会(IAS)严重家族性高胆固醇血症小组发布了关于严重家族性高胆固醇血症的定义和临床管理意义的共识声明，文章评估了分子生物学特征的重要性以及其他心血管危险因素，晚期亚临床冠状动脉粥样硬化的定义，严重家族性高胆固醇血症患者可从早期积极降脂治疗中获益。

相关资料下载：
[AttachmentFileName(sort=100, fileName=2016 IAS共识声明：严重家族性高胆固醇血症的定义和临床管理意义)] GetToolGuiderByIdResponse(projectId=1, id=b27f11c001290047, title=2016 IAS共识声明：严重家族性高胆固醇血症的定义和临床管理意义, enTitle=Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel., guiderFrom=Lancet Diabetes Endocrinol. 2016 May 27, authorId=null, author=, summary=2016年5月，国际动脉粥样硬化学会(IAS)严重家族性高胆固醇血症小组发布了关于严重家族性高胆固醇血症的定义和临床管理意义的共识声明，文章评估了分子生物学特征的重要性以及其他心血管危险因素，晚期亚临床冠状动脉粥样硬化的定义，严重家族性高胆固醇血症患者可从早期积极降脂治疗中获益。, cover=, journalId=null, articlesId=null, associationId=798, associationName=国际动脉粥样硬化学会, associationIntro=null, copyright=0, guiderPublishedTime=Fri May 27 00:00:00 CST 2016, originalUrl=, linkOutUrl=, content=2016年5月，国际动脉粥样硬化学会(IAS)严重家族性高胆固醇血症小组发布了关于严重家族性高胆固醇血症的定义和临床管理意义的共识声明，文章评估了分子生物学特征的重要性以及其他心血管危险因素，晚期亚临床冠状动脉粥样硬化的定义，严重家族性高胆固醇血症患者可从早期积极降脂治疗中获益。<div><br> 拓展指南：<strong>与<font color="red">高胆固醇血症</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=95f4e1c001116e64" title="2014 CCS立场声明：家族性高胆固醇血症" target="_blank">2014 CCS立场声明：家族性高胆固醇血症</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=b7bff1c001092a61" title="2014 EAS意见书：改善纯合体家族性高胆固醇血症的检测与管理" target="_blank">2014 EAS意见书：改善纯合体家族性高胆固醇血症的检测与管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=b3cd21c0010a9938" title="2014 国际家族性高胆固醇血症基金会患者管理的整合指南" target="_blank">2014 国际家族性高胆固醇血症基金会患者管理的整合指南</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=e87b51c001013a47" title="2013 EAS家族性高胆固醇血症诊治共识" target="_blank">2013 EAS家族性高胆固醇血症诊治共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=259b01c0008a0ed8" title="2011美国国家脂质协会儿童和成人家族性高胆固醇血症患者管理" target="_blank">2011美国国家脂质协会儿童和成人家族性高胆固醇血症患者管理</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E9%AB%98%E8%83%86%E5%9B%BA%E9%86%87%E8%A1%80%E7%97%87" target="_blank">有关高胆固醇血症更多指南</a></ul></div>, tagList=[TagDto(tagId=892, tagName=高胆固醇血症)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4364, appHits=99, showAppHits=0, pcHits=3486, showPcHits=1503, likes=157, shares=4, comments=33, approvalStatus=1, publishedTime=Wed Sep 28 00:16:38 CST 2016, publishedTimeString=2016-05-27, pcVisible=1, appVisible=1, editorId=5295957, editor=lili, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=lili, createdTime=Wed Sep 28 00:16:38 CST 2016, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 16:07:47 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2016 IAS共识声明：严重家族性高胆固醇血症的定义和临床管理意义)])
2016 IAS共识声明：严重家族性高胆固醇血症的定义和临床管理意义
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=969715, encodeId=0c10969e15d7, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef2c1960942, createdName=1e1366a1m07(暂无匿称), createdTime=Sun May 30 23:24:40 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138399, encodeId=5e2d138399e0, content=好 学习了 谢谢 谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQpl0ENSJScphsFtdgfibXX1g1IuEYGCjP23UqCd52TxTpSZibtPiclyusaHicnNXd78alaia19Qy1nAFo18/0, createdBy=50381491660, createdName=zwjnj2, createdTime=Sat Oct 01 08:06:00 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137027, encodeId=0f2b13e0276e, content=家族性的也少见过，分不同的类型，具体用药是模糊地带, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Wed Sep 28 15:43:49 CST 2016, time=2016-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=136823, encodeId=b02a1368230e, content=谢谢，指南学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Wed Sep 28 07:21:41 CST 2016, time=2016-09-28, status=1, ipAttribution=)]
    2021-05-30 1e1366a1m07(暂无匿称)

    谢谢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=969715, encodeId=0c10969e15d7, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef2c1960942, createdName=1e1366a1m07(暂无匿称), createdTime=Sun May 30 23:24:40 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138399, encodeId=5e2d138399e0, content=好 学习了 谢谢 谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQpl0ENSJScphsFtdgfibXX1g1IuEYGCjP23UqCd52TxTpSZibtPiclyusaHicnNXd78alaia19Qy1nAFo18/0, createdBy=50381491660, createdName=zwjnj2, createdTime=Sat Oct 01 08:06:00 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137027, encodeId=0f2b13e0276e, content=家族性的也少见过，分不同的类型，具体用药是模糊地带, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Wed Sep 28 15:43:49 CST 2016, time=2016-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=136823, encodeId=b02a1368230e, content=谢谢，指南学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Wed Sep 28 07:21:41 CST 2016, time=2016-09-28, status=1, ipAttribution=)]
    2016-10-01 zwjnj2

    好 学习了 谢谢 谢谢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=969715, encodeId=0c10969e15d7, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef2c1960942, createdName=1e1366a1m07(暂无匿称), createdTime=Sun May 30 23:24:40 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138399, encodeId=5e2d138399e0, content=好 学习了 谢谢 谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQpl0ENSJScphsFtdgfibXX1g1IuEYGCjP23UqCd52TxTpSZibtPiclyusaHicnNXd78alaia19Qy1nAFo18/0, createdBy=50381491660, createdName=zwjnj2, createdTime=Sat Oct 01 08:06:00 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137027, encodeId=0f2b13e0276e, content=家族性的也少见过，分不同的类型，具体用药是模糊地带, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Wed Sep 28 15:43:49 CST 2016, time=2016-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=136823, encodeId=b02a1368230e, content=谢谢，指南学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Wed Sep 28 07:21:41 CST 2016, time=2016-09-28, status=1, ipAttribution=)]
    2016-09-28 有备才能无患

    家族性的也少见过，分不同的类型，具体用药是模糊地带

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=969715, encodeId=0c10969e15d7, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef2c1960942, createdName=1e1366a1m07(暂无匿称), createdTime=Sun May 30 23:24:40 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=138399, encodeId=5e2d138399e0, content=好 学习了 谢谢 谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6DGOvNrRdcib3UmzMgpEQpl0ENSJScphsFtdgfibXX1g1IuEYGCjP23UqCd52TxTpSZibtPiclyusaHicnNXd78alaia19Qy1nAFo18/0, createdBy=50381491660, createdName=zwjnj2, createdTime=Sat Oct 01 08:06:00 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=137027, encodeId=0f2b13e0276e, content=家族性的也少见过，分不同的类型，具体用药是模糊地带, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Wed Sep 28 15:43:49 CST 2016, time=2016-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=136823, encodeId=b02a1368230e, content=谢谢，指南学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Wed Sep 28 07:21:41 CST 2016, time=2016-09-28, status=1, ipAttribution=)]
    2016-09-28 flysky120

    谢谢，指南学习

    0